Renata Medical closed a $25 million Series D led by ARCHIMED to commercialize its pediatric stent, enter international markets, and advance its product pipeline.
- Amount
- $25M
- Stage
- Series D
- Announced
- 19 August 2026
- Lead
- ARCHIMED
- Use of funds
- Expanded U.S. commercialization of Minima, international market entry, pipeline advancement, and clinical evidence generation
- Checked
- Announced by the company